Informations générales (source: ClinicalTrials.gov)

NCT03900221 En recrutement IDF
French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Observational [Patient Registry]
  • Allaitement naturel
  • Maladie
  • Sclérose en plaques
  • Neuromyélite optique
  • Sclérose
Hospices Civils de Lyon (Voir sur ClinicalTrials)
août 2019
août 2036
02 février 2026
The influence of pregnancy on the course of multiple sclerosis (MS) has long been a controversial topic. After the publication of the first large prospective study of pregnancy and MS in 1998, counselling of women with MS has radically changed and many patients have been able to fulfill their desire of motherhood. However, there are still some challenges for the neurologist, who has to face old unanswered questions or new issues, regarding the use of disease modifying drugs (DMDs) in this period of life, effects on the short and long term outcome of the mother (in terms of relapses and disability) and the child, role of breast-feeding and locoregional analgesia. To set up a national prospective pregnancy registry for patients with MS, nested within the Observatoire Français de la Sclérose en Plaque (OFSEP) cohort, owing to a better knowledge of interactions between MS and pregnancy-related issues (pregnancy itself, locoregional analgesia, breastfeeding, impact of using or stopping DMDs on women/children…)
 Voir le détail

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
CENTRE HOSPITALIER SUD FRANCILIEN POTTIER En recrutement IDF 09/06/2024 11:48:13  Contacter
HOPITAL FOCH MAIA TCHIKVILADZE Recrutement non commencé 02/02/2026 08:25:46  Contacter
HOPITAL FOCH MAIA TCHIKVILADZE Recrutement non commencé 26/01/2026 08:40:46  Contacter
HOPITAL FONDATION A. DE ROTHSCHILD Caroline BENSA En recrutement IDF 21/06/2024 13:32:59  Contacter
HOPITAL NOVO POTTIER En recrutement IDF 18/09/2025 17:50:12  Contacter
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
AP-HP - Hôpital Henri Mondor-Albert Chenevier Alain CREANGE Contact (sur clinicalTrials)
AP-HP - Hôpital La Pitié-Salpêtrière Elisabeth MAILLART Contact (sur clinicalTrials)
CENTRE HOSPITALIER DE GONESSE Eric MANCHON Contact (sur clinicalTrials)
CH DE VERSAILLES SITE ANDRE MIGNOT Chantal NIEFLE Contact (sur clinicalTrials)
CHI POISSY ST-GERMAIN Olivier HEINZLEF Contact (sur clinicalTrials)
GH PARIS SITE SAINT JOSEPH Hélène BRASME Contact (sur clinicalTrials)
HOPITAL NOVO Corinne DUPEL-POTTIER Contact (sur clinicalTrials)
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Centre Hospitalier Annecy Genevois - 74000 - Annecy 3037543 - France Nathalie MOREL Contact (sur clinicalTrials)
Centre Hospitalier d'Avignon - 84000 - Avignon 3035681 - France Patricia TOURNAIRE Contact (sur clinicalTrials)
Centre hospitalier Métropole Savoie - 73000 - Chambéry 3027422 - France Clara GROSSET-JANIN Contact (sur clinicalTrials)
Ch Epinal - 88000 - Épinal 3020035 - France Evelyne PLANQUE Contact (sur clinicalTrials)
Chr La Miletrie - 86021 - Poitiers 2986495 - France Amélie DOS SANTO Contact (sur clinicalTrials)
Chu de Grenoble - 38043 - Grenoble 3014728 - France Olivier CASEZ Contact (sur clinicalTrials)
Hôpital Central - 54035 - Nancy 2990999 - France Guillaume MATHEY Contact (sur clinicalTrials)
Hopital Du Bocage - 21079 - Dijon 3021372 - France Thibault MOREAU Contact (sur clinicalTrials)
Hopital Dupuytren - 87042 - Limoges 2998286 - France Laurent MAGY Contact (sur clinicalTrials)
Hopital G. Et R. Laennec - 44800 - Saint-Herblain 2979590 - France David LAPLAUD Contact (sur clinicalTrials)
Hopital Gui de Chauliac - 34295 - Montpellier 2992166 - France Pierre LABAUGE Contact (sur clinicalTrials)
Hopital Pasteur - 06001 - Nice 2990440 - France Christine LEBRUN-FRENAY Contact (sur clinicalTrials)
Hopital Purpan - 31059 - Toulouse 2972315 - France Jonathan CIRON Contact (sur clinicalTrials)
Hôpital St Vincent De Paul - 59020 - Lille 2998324 - France Arnaud KWIATKOWSKI Contact (sur clinicalTrials)
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Cabinet médical Dr C. CORNUT-CHAUVINC - 69008 - Lyon 2996944 - France Catherine CORNUT- CHAUVINC Contact (sur clinicalTrials)
Cabinet médical Dr L. GUILLOTON - 69440 - Mornant 2991743 - France Laurent GUILLOTON Contact (sur clinicalTrials)
Cabinet médical Dr Philippe NEUSCHWANDER - 69006 - Lyon 2996944 - France Philippe NEUSCHWANDER Contact (sur clinicalTrials)
Centre Hospitalier de Saint-Denis - 93200 - Saint-Denis 2980916 - France Thomas DEBROUCKER Contact (sur clinicalTrials)
Centre Hospitalier Mémorial - 50009 - Saint-Lô 2978758 - France Lydie DUBUC-LEPETIT Contact (sur clinicalTrials)
Centre Hospitalier Saint Joseph Saint Luc - 69007 - Lyon 2996944 - France Amandine BENOIT Contact (sur clinicalTrials)
Chru de Lille - 59037 - Lille 2998324 - France Hélène ZEPHIR Contact (sur clinicalTrials)
Chru de Tours Hopital Bretonneau - 37044 - Tours 2972191 - France Ines DOGHRI Contact (sur clinicalTrials)
Chu D'Amiens - 80054 - Amiens 3037854 - France Abdullatif AL KHEDR Contact (sur clinicalTrials)
Fondation Rotschild - 75019 - Paris 2988507 - France Caroline BENSA-KOSCHER Contact (sur clinicalTrials)
Hopital Caremeau - 30029 - Nîmes 2990363 - France Eric THOUVENOT Contact (sur clinicalTrials)
Hôpital Charles-Nicolle - 76000 - Rouen 2982652 - France Bertrand BOURRE Contact (sur clinicalTrials)
Hopital Cote de Nacre - 14033 - Caen 3029241 - France Pierre BRANGER Contact (sur clinicalTrials)
Hôpital de Brive - 19100 - Brive-la-Gaillarde 3029974 - France Alexis MONTCUQUET Contact (sur clinicalTrials)
Hopital Gabriel Montpied - 63003 - Clermont-Ferrand 3024635 - France Pierre CLAVELOU Contact (sur clinicalTrials)
Hopital Hautepierre - 67098 - Strasbourg 2973783 - France Jérôme DE SEZE Contact (sur clinicalTrials)
Hopital Jean Minjoz - 25030 - Besançon 3033123 - France Eric BERGER Contact (sur clinicalTrials)
Hôpital national des Quinze-Vingt. - 75571 - Paris 2988507 - France Dalia DIMITRI BOULOS Contact (sur clinicalTrials)
Hôpital Neurologique Pierre Wertheimer - 69677 - Bron 3029931 - France Sandra VUKUSIC Contact (sur clinicalTrials)
Hopital Nord - 42277 - Saint-Priest-en-Jarez 2977350 - France Jean-Philippe CAMDESSANCHE Contact (sur clinicalTrials)
Hopital Pellegrin - 33076 - Bordeaux 3031582 - France Aurélie RUET Contact (sur clinicalTrials)
Hopital Pontchaillou - 35033 - Rennes 2983990 - France Laure MICHEL Contact (sur clinicalTrials)
Hôpital Raymond Poincaré - 92380 - Garches 3016675 - France Ayman TOURBAH Contact (sur clinicalTrials)
Hopital Timone Adultes - 13385 - Marseille 2995469 - France Jean PELLETIER Contact (sur clinicalTrials)
Médipôle Lyon Villeurbanne - 69100 - Villeurbanne 2968254 - France Pékès CODJA Contact (sur clinicalTrials)

Critères

Tous


- All groups of patients eligible to participate to the Observatoire Français de la
Sclérose en Plaque (OFSEP), including :

- Definite Multiple sclerosis (MS) according to McDonald criteria

- Whatever the clinical course (single attack MS, relapsing-remitting MS, secondary
progressive MS, primary progressive MS)

- Radiologically Isolated Syndromes (RIS) (will be validated by the RIS expert group)

- Clinically Isolated Syndromes (CIS)

- Neuromyelitis optica (NMO) and NMO spectrum disorders (will be validated by the
"Neuro-optico-myélite aiguë de Devic et des syndromes neurologiques apparentés"
(NOMADMUS) expert group)

- No age limit (patients under the age of 18 might be included, provided informed
consent is obtained from the parents)

- Ongoing pregnancy: there will be no limit in the gestational age at inclusion. Women
can be included at any time before delivery, but the gestational age at inclusion
will be recorded and introduced in the analyses whenever pertinent. However,
neurologists and patients will be encouraged to start the study as soon as pregnancy
is diagnosed.

- Able to give informed consent

- Able to read and/or understand French

Exclusion Criteria:


- None